Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Multiple doses of intravenous echinocandin CD-101 safe and well tolerated in phase I study

July 11, 2016

Evotec collaborates with Antibiotic Research UK to tackle antibiotic resistance

July 11, 2016

Gilead Sciences obtains European marketing authorization for Epclusa

July 11, 2016

Valneva develops Zika virus vaccine

July 11, 2016

Alnylam initiates phase I/II trial of ALN-HBV to treat chronic HBV infection

July 8, 2016

Seres Therapeutics begins phase Ib trial of microbiome therapeutic

July 8, 2016

MicuRx Pharmaceuticals introduces antibacterial compounds

July 8, 2016

First clinical data reported for novel ketolide WCK-4873

July 8, 2016

New PREVAIL trial opens in Liberia for men with Ebola virus RNA detected in semen

July 7, 2016

Alios BioPharma patents NS5B inhibitors

July 7, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...